SCHEMBL24344763

SCHEMBL24344763

C[SiH2]c1ccc(C)cc1C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
TYR P14679 2/20 0.41
CA2 P00918 1/20 0.41
POLB P06746 1/20 0.41
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
TSHR P16473 2/20 0.36
HSPA5 P11021 1/20 0.34
CYP1A2 P05177 3/20 0.33
CYP2C9 P11712 3/20 0.33
CYP2A6 P11509 2/20 0.33
CYP2C19 P33261 2/20 0.33
HIF1A Q16665 2/20 0.33
TDP1 Q9NUW8 2/20 0.32
KDM4E B2RXH2 3/20 0.32
MAPT P10636 3/20 0.32
HPGD P15428 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17594923 0.74 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2TYRCA2POLB
SCHEMBL24344710 0.74 CYP2D6 (0.36) ALDH1A1TYRPTGS1CYP1A2CYP2C9
SCHEMBL3166363 0.72 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2TYRCA2POLB
SCHEMBL4451465 0.68 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2TYRCA2POLB
SCHEMBL270433 0.68 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2TYRCA2POLB
SCHEMBL16355402 0.68 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2TYRCA2POLB
SCHEMBL4457738 0.68 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2TYRCA2POLB
SCHEMBL1690352 0.68 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2TYRCA2POLB
SCHEMBL21692816 0.68 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2TYRCA2POLB
SCHEMBL333952 0.68 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2TYRCA2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220085302-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220085302-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LIFR, LBR, EPOR ALDH1A1 911/4885SMN1; SMN2 3509/4885TYR 333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.